Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $13.77 in the prior trading day, Contineum Therapeutics Inc (NASDAQ: CTNM) closed at $13.37, down -2.90%. In other words, the price has decreased by -$2.90 from its previous closing price. On the day, 0.2 million shares were traded. CTNM stock price reached its highest trading level at $13.615 during the session, while it also had its lowest trading level at $12.99.
Ratios:
Our goal is to gain a better understanding of CTNM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 37.06 and its Current Ratio is at 37.06. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on October 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $32.
On April 30, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $29.
On April 30, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $30.RBC Capital Mkts initiated its Outperform rating on April 30, 2024, with a $30 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 ’24 when Lorrain Daniel S. sold 1,010 shares for $16.02 per share. The transaction valued at 16,177 led to the insider holds 168,562 shares of the business.
Lorrain Daniel S. sold 6,190 shares of CTNM for $101,421 on Nov 18 ’24. The Chief Scientific Officer now owns 169,572 shares after completing the transaction at $16.38 per share. On Nov 18 ’24, another insider, DANIEL LORRAIN, who serves as the Officer of the company, bought 26,370 shares for $17.21 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTNM now has a Market Capitalization of 344649184 and an Enterprise Value of 131349096.
Stock Price History:
Over the past 52 weeks, CTNM has reached a high of $22.00, while it has fallen to a 52-week low of $12.33. The 50-Day Moving Average of the stock is -12.59%, while the 200-Day Moving Average is calculated to be -21.28%.
Shares Statistics:
The stock has traded on average 92.76K shares per day over the past 3-months and 80720 shares per day over the last 10 days, according to various share statistics. A total of 19.01M shares are outstanding, with a floating share count of 14.07M. Insiders hold about 45.42% of the company’s shares, while institutions hold 39.94% stake in the company. Shares short for CTNM as of 1734048000 were 983606 with a Short Ratio of 10.60, compared to 1731628800 on 1047495.
